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Plasmodium cysteine proteases are essential for
host-cell invasion and egress, hemoglobin degrada-
tion, and intracellular development of the parasite.
The temporal, site-specific regulation of cysteine-
protease activity is a prerequisite for survival and
propagation of Plasmodium. Recently, a new family
of inhibitors of cysteine proteases (ICPs) with homo-
logs in at least eight Plasmodium species has been
identified. Here, we report the 2.6 A˚ X-ray crystal
structure of the C-terminal, inhibitory domain of ICP
from P. berghei (PbICP-C) in a 1:1 complex with falci-
pain-2, an important hemoglobinase of Plasmodium.
The structure establishes Plasmodium ICP as
a member of the I42 class of chagasin-like protease
inhibitors but with large insertions and differences
in the bindingmode relative to other family members.
Furthermore, the PbICP-C structure explains why
host-cell cathepsin B-like proteases and, most likely,
also the protease-like domain of Plasmodium SERA5
(serine-repeat antigen 5) are no targets for ICP.
INTRODUCTION
Malaria is a devastating disease caused by apicomplexan para-
sites of the genus Plasmodium. With close to 1million deaths per
year and an estimated 250million people affected, malaria is one
of the biggest health care problems worldwide (World Health
Organization, 2009). In the human host the complex life cycle
ofPlasmodium involves a liver stage and a blood stagewith intra-
cellular forms of the parasite in hepatocytes and erythrocytes,
respectively. Plasmodium cysteine proteases (CPs) play impor-
tant roles during both stages, facilitating activation of proen-
zymes, hemoglobin degradation, and uptake as well as egress
from host cells (Coppens et al., 2010; Drew et al., 2008; Hogg
et al., 2006; Rosenthal, 2004; Sturm et al., 2009). Furthermore,Structure 19,CPs of the parasite are thought to mediate an unusual form of
programmed host-cell death that clearly differs from apoptosis
(Heussler et al., 2010; Sturm et al., 2006). It has been shown
that CP activity is essential for the development of the parasite
in its vector, the Anopheles mosquito (Aly and Matuschewski,
2005), further stressing the importance of this class of enzymes
for Plasmodium. In addition to intrinsic CPs of the parasite, CPs
of the human host are also highly relevant for Plasmodium
because these enzymes are part of the protective defense
system. Host-cell CPs play roles in mechanisms as diverse as
antigen presentation of parasite-derived material, cytokine
responses, host-cell apoptosis, and direct intra- or extracellular
destruction of parasites (Blott and Griffiths, 2002; Luzio et al.,
2007; Manoury et al., 2001; Murray et al., 2005; Sa-Nunes
et al., 2009; Schierack et al., 2003; Schnoeller et al., 2008).
Taking the pivotal importance of CPs for survival and propaga-
tion of the parasite into account, it is evident that Plasmodium
needs effective means to control the activity of these enzymes
in a site-specific and time-dependent manner. According to
sequence data, genes encoding inhibitors of cysteine proteases
(ICPs) are present in at least eight Plasmodium species.
Recently, we showed that ICP from P. berghei (PbICP) and
the C-terminal domain of PbICP (PbICP-C) alone act as potent
inhibitors of falcipain-2 (FP-2) and other CPs. Furthermore, we
demonstrated that PbICP is critical for hepatocyte invasion by
sporozoites and is able to block host-cell apoptosis (Rennen-
berg et al., 2010). Similarly, ICP from P. falciparum (PfICP or
falstatin) has been shown to inhibit a wide range of parasite
and host-cell proteases and to facilitate parasite invasion of
erythrocytes (Pandey et al., 2006).
FP-2 is a well-characterized papain-like CP of P. falciparum
with critical importance for the parasite (Rosenthal, 2004);
hence, it is the target of intensive drug design efforts (see, for
example, Li et al., 2009). Its main function is to degrade host-
cell hemoglobin, which represents the major nutrient source of
the intracellular parasite (Rosenthal, 2004), but FP-2 is also
able to activate at least one other protease (plasmepsin 2) by
cleaving off the propeptide (Drew et al., 2008). Furthermore,
FP-2 has been shown to hydrolyze erythrocyte cytoskeletal
proteins in vitro (Hanspal et al., 2002) and might, therefore,919–929, July 13, 2011 ª2011 Elsevier Ltd All rights reserved 919
Table 1. Data Collection and Refinement Statistics
A. Data Collection
Wavelength (A˚) 0.9184
Temperature (K) 100
Resolution (A˚) 34.89–2.60 (2.74–2.60)
Space group P43
Unit cell parameters
a = b (A˚) 71.15
c (A˚) 120.13
Solvent content (%, v/v) 61.0
Unique reflections 17570 (2640)
Multiplicity 4.2 (4.1)
Completeness (%) 95.2 (96.6)
Rmerge
a 0.101 (0.507)
Rpim
b 0.052 (0.283)
I/s(I) 8.1 (2.5)
B. Refinement
Rcryst
c 0.181
Rfree
d 0.229
Rmsd from ideal geometry
Bonds (A˚) 0.010
Angles () 0.949
Average B factor (A˚2)
FP-2 55.17
PbICP-C 78.23
Water 51.73
Ramachandran plot regions (%)
Most favored (%) 85.3
Additionally allowed (%) 14.4
Outlier (%) 0.3
PDB code 3PNR
Values in parentheses are for highest-resolution shell.
a Rmerge = Shkl SijI(hkl)i  <I(hkl)>j/ Shkl Si I(hkl)i, where I(hkl) is the intensity
of reflection hkl, and <I(hkl)> is the average intensity over all equivalent
reflections.
b Rpim is the precision-indicating merging R factor (Weiss and Hilgenfeld,
1997).
c Rcryst = Shkl jFo(hkl)  Fc(hkl)j/Shkl Fo (hkl).
d Rfree was calculated for a test set of reflections (5%) omitted from the
refinement.
Structure
Structure of PbICP-C in Complex with FP-2play a role in the escape of the parasite from the erythrocyte. It
may well act in concert with proteins of the SERA (serine-repeat
antigen) family, which are produced in large quantities at the time
of egress and are thought to be key players in this process
(Blackman, 2008). Because FP-2 is one of the most abundant
CPs of intraerythrocyte parasites, it is likely released during
rupture of late schizonts. It has been proposed that Plasmodium
ICP controls the activity of FP-2 and other CPs of the parasite at
this stage, thereby preventing detrimental protease activity that
could interfere with the subsequent invasion of another host
cell (Pandey et al., 2006).
Here, we report the first three-dimensional structure of the
inhibitory C-terminal domain of ICP (ICP-C) from Plasmodium.
The structure of PbICP-C was determined in complex with920 Structure 19, 919–929, July 13, 2011 ª2011 Elsevier Ltd All rightFP-2 from P. falciparum. The results establish the PbICP-C as
a member of the MEROPS I42 family of inhibitors, the founding
member of which is chagasin of Trypanosoma cruzi (Monteiro
et al., 2001). I42 family members are small proteins (110–130
amino acid residues), whereas Plasmodium ICPs comprise at
least 350 residues. In the latter a unique, nonhomologous
N-terminal domain (ICP-N; 190 residues) precedes the chaga-
sin-like ICP-C (160 residues; 300 residues in P. gallinaceum).
Even in ICP-C, sequence similarity to chagasin is low (20%
amino acid identity, 40%–50% amino acid similarity), and there
are unique sequence-insertion elements and four instead of
three protease-binding loops. Mutational studies suggest that
in addition, the insertion element in loop L3 might participate in
protease binding. The structure of the macromolecular complex
with FP-2 identifies the binding epitopes and illustrates themode
of interaction of Plasmodium ICPs with FP-2 and other possible
targets.
RESULTS AND DISCUSSION
Overall Structure of PbICP-C
In order to shed light on the basis of the interaction between
Plasmodium ICPs and target proteases, we determined the
structure of PbICP-C in complex with FP-2 by X-ray crystallog-
raphy. PbICP-C and the catalytically inactive Cys42Ala variant
of mature FP-2 were produced in E. coli and purified to homoge-
neity as reported previously (Hogg et al., 2006; Rennenberg
et al., 2010). Subsequently, the binary complex of PbICP-C
and FP-2 was prepared and crystallized. Diffraction data to
a resolution of 2.6 A˚ were collected, and the structure of the
complex was determined (Table 1).
The refined structure includes 1 copy of the PbICP-C:FP-2
complex, 54 water molecules, 3 glycerol molecules, and 2 tightly
bound Cd2+ ions in the asymmetric unit (Cd2+, used as an addi-
tive in crystallization of the complex, forms intermolecular
contacts in the crystal lattice). The final model includes amino
acid residues 195–275 and 307–354 of PbICP and residues
2–241 of mature FP-2.
PbICP-C adopts an Ig-like b sandwich structure comprising
ten b strands organized in two b sheets (Figure 1). The front sheet
(referring to the orientation shown in Figure 1A, right panel)
comprises four strands of eight to ten residues in length, with
strands b4, b7, and b8 being in an antiparallel orientation to
one another and b2 aligned in parallel to b8 (Figures 1A and
1B). The predominantly antiparallel back sheet includes strands
b1, b3, b5, b50, b500, and b6, with b1 and the short strands b5, b50,
and b500 framing b3 and b6 in the center. The front and back
sheets enclose a cluster of hydrophobic amino acid residues
that forms the core of the structure (Figure 1C). These residues
are responsible for an alternating pattern of conserved and non-
conserved residues along the b strands of PbICP-C, as is typical
for Ig-fold proteins. The b strands are connected by loops L0, L2,
L4, and L6, the latter three corresponding to the complemen-
tarity-determining regions (CDRs) in immunoglobulins. It is these
loops that protrude into the substrate-binding site of FP-2 and
are responsible for a large part of the interaction between the
two proteins.
A Dali (Holm et al., 2008) search revealed chagasin, the found-
ing member of the MEROPS I42 family of inhibitors, as closests reserved
Figure 1. Overall Structure of PbICP-C
(A) Orthogonal views on the overall structure of
PbICP-C in ribbon representation, with b strands
of the front sheet and the back sheet shown in
green and dark green, respectively. The prominent
loop regions on one end of PbICP-C are shown in
purple (L0), blue (L2), red (L4), and cyan (L6). The
dashed line indicates a flexible region in L4 not
defined by electron density.
(B) Topology diagram of PbICP-C with colors as
in (A).
(C) Residues involved in hydrophobic contacts
in the core of PbICP-C depicted with 2Fo-Fc
electron density contoured at 1s (blue).
(D) Ribbon representation of chagasin (light blue)
and LmICP (brown) in an orientation as PbICP-C in
(A), right panel. Loops L2, L4, and L6 are colored
as in (A).
(E) Domain organization of PbICP with signal
peptide (red, ‘‘SP’’), PbICP-N (gray), and PbICP-C
(green) (top panel). Sequence alignment of inhibi-
tory domains of PbICP-C, PfICP-C, chagasin, and
LmICP, with PbICP residue numbering indicated
(bottom panel). Amino acid residues in flexible
regions are depicted in gray. Secondary-structure
elements of PbICP-C, chagasin, and LmICP are
boxed in green (b strands), purple (a helices), and
gray (310 helices). Loop regions L2, L4, L6, and L0
(only PbICP-C) are boxed and colored as in (A).
See also Figure S1.
Structure
Structure of PbICP-C in Complex with FP-2structural homolog with a Z score of 10.6. Rmsds between
PbICP-C and various crystal and solution structures of free
chagasin amount to 1.7–1.9 A˚ (based on 79–91 common Ca
atoms; PDB codes: 2H7W, 2NNR, 2FO8) (Figueiredo da Silva
et al., 2007; Ljunggren et al., 2007; Salmon et al., 2006) (Fig-
ure 1D). PbICP-C shares less similarities (Dali Z score 8.2,
rmsd 3.1 A˚, based on 65 commonCa atoms) with the other struc-
turally characterized chagasin-like inhibitor, a CP inhibitor from
Leishmania mexicana (LmICP) (Smith et al., 2006; PDB code:
2C34) (Figure 1D).
Loops L2 (residues 230–234), L4 (residues 275–312), and L6
(residues 336–344) of PbICP-C exist in chagasin as well and
include sequence motifs conserved in the I42 family (Rigden
et al., 2002). However, an additional fourth loop (residues 201–
207) designated L0 and connecting b1 and b2 is located at the
same end of the PbICP-C molecule (Figures 1A and 1B). Three
amino acid residues in this loop (Gly201, Ile203, and Asn205)
are highly conserved in Plasmodium ICPs, but not in other I42
family members (Figure 1E). The apex of L0 in PbICP-CStructure 19, 919–929, July 13, 2011protrudes from the two core b sheets as
far as do L2, L4, and L6 (Figure 1A),
enabling it to get involved in interactions
with target CPs.
Outside the conserved Ig-like core, the
overall architecture of PbICP-C differs
from chagasin and LmICP and includes
structural elements not present in the
latter two. Thus, there is an insertion
comprising 29 residues (277–305) in the
L4 loop. This polypeptide segment ishighly flexible and not defined by electron density. In contrast
a second insertion (residues 250–264) is well ordered; it extends
L3 relative to that of chagasin and also includes helix a1 and the
short strand b5 in PbICP-C. The extended L3 loop is anchored to
the outer face of the front sheet and covers a cluster of hydro-
phobic residues that would be exposed to the solvent if not
buried by hydrophobic residues of the loop (see Figure S1A
available online). L3 is followed by three short b strands (b5,
b50, and b500) instead of one continuous b5 as in chagasin.
Structural Determinants of the Interaction between
PbICP-C and FP-2
Kinetic studies showed that PbICP, PfICP, their C-terminal
domains alone and chagasin are very effective inhibitors of
FP-2 with Ki values in the nanomolar range (Table 2). This agrees
well with Ki values for FP-2 inhibition by chagasin or cystatin
reported by Wang et al. (2007). Indeed, even subnanomolar Ki
values have been reported for PfICP against various CPs (Pan-
dey et al., 2006). Our X-ray structure revealed that PbICP-Cª2011 Elsevier Ltd All rights reserved 921
Table 2. Inhibition Constants of PbICP-C, PfICP-C, and Chagasin
against FP-2
Protease Inhibitor Ki (nM)
PbICP-C 11.9 ± 4.7
MBP-PbICP-C 8.7 ± 1.8
MBP-PbICP 10.2 ± 2.9
PfICP-C 35.9 ± 12.65
MBP-PfICP-C 23.0 ± 5.7
MBP-PfICP 37.1 ± 5.4
MBP-chagasin 4.8 ± 1.7
Structure
Structure of PbICP-C in Complex with FP-2and FP-2 form a stable 1:1 complex with a buried surface area of
2650 A˚2, comprising 17.7% and 10.8% of the total solvent-
accessible surface of PbICP-C and FP-2, respectively. A super-
imposition of FP-2 in the PbICP-C complex with free FP-2 (Hogg
et al., 2006) revealed no large conformational rearrangements of
the protease (rmsd 0.63 A˚ for Ca atoms).
PbICP-C uses its four loops (L0, L2, L4, and L6) for binding to
the target protease (Figure 2). Loop L2 binds to the primed
subsites S10 and S20 of the substrate-binding cleft of FP-2 and
blocks access to the active site. S10 is occupied by residues
Ala230i and Gly231i, and S20 accommodates the side chain of
Thr232i (in the following, an appended ‘‘p’’ or ‘‘i’’ indicates
protease or inhibitor residues, respectively). L2 is held in place
by a hydrogen bond between the Gly231i carbonyl and the
Trp206p indol nitrogen (Figure 2, inset L2). Interestingly, the I42
family L2 consensus motif NPTTG is replaced by 229NAGTG233
in PbICP. To examine the effect of this substitution, we replaced
NAGTG of PbICP-C by NPTTG and measured the capability of
the variant (PbICP-CMut1) to inhibit various proteases. Surpris-922 Structure 19, 919–929, July 13, 2011 ª2011 Elsevier Ltd All rightingly, we could not detect any significant difference between
PbICP-CMut1 and wild-type PbICP-C in the inhibition of FP-2,
papain, and CPs present in lysates of Entamoeba histolytica
(EhCPs) (Figure 3).
PbICP-C L4 residues 307MQLLGG312 bind into the active site
cleft of the protease in the vicinity of the catalytic Cys42p and
occupy the nonprimed substrate-interaction pockets S1–S3
(Figure 2). S1 accommodates Gly311i, which is anchored to
the substrate-binding cleft by a strong main-chain hydrogen
bond to Asn173p (Figure 2, inset L4). The side chain of Leu310i
is located in the hydrophobic S2 specificity pocket; the back-
bone of Leu310i is fixed in a b sheet-like fashion by two hydrogen
bonds with Gly83p. The predominantly hydrophobic S3 subsite
holds the side chain of Leu309i. L4 residues N-terminal of
Met307i are very flexible and not defined by electron density in
the crystal structure. Accordingly, removal of residues in this
region (PbICP-CMut2, residues 273–297 replaced by GGG, Fig-
ure 3) does not affect inhibition of proteases by PbICP-C, indi-
cating that it is dispensable for the interaction with FP-2, as
well as with papain and EhCPs. Interestingly, in P. gallinaceum
ICP (previously designated PgSES), L4 is even more extended
and comprises ten imperfect six amino acid repeats (residues
436i–495i) (LaCrue et al., 2006). The function of such repeat
regions in Plasmodium proteins is unknown.
The interaction of loop L6 is dominated by Arg336i, which rea-
ches into the catalytic cleft of FP-2 at a position that might
accommodate P40 or P50 residues of substrates (Figure 2).
Arg336i is of pivotal importance for PbICP-C because it fulfills
two functions: (1) it forms a strong salt bridge to the carboxylate
of Asp35p (Figure 2, inset L6), contributing to the overall stability
of the complex; and (2) its guanidinium group hydrogen bonds to
the main-chain carbonyl of Thr232i, effectively interlinking L6Figure 2. Structure of the PbICP-C:FP-2
Complex
Complex of PbICP-C (ribbon representation) and
FP-2 (surface representation, gray). The top panel
displays the L0, L2, L4, and L6 loops on the
surface of FP-2 with S10 and S20 sites indicated
(orange). Details of interactions between L0, L2,
L4, L6, and FP-2 are shown as insets. Interacting
residues of PbICP-C and FP-2 are indicated and
shown as sticks; hydrogen bonds are shown as
dashed lines. See also Figure S2.
s reserved
Figure 3. Effect of PbICP-C and PbICP-
CMut1–5 Variants on Cysteine-Protease
Activity
The proteolysis of chromogenic peptide sub-
strates by FP-2, papain, cathepsin B, and a lysate
of E. histolytica (EhCPs) was determined in
the presence of PbICP-C or PbICP-CMut1–5
(PbICP-CMut1: residues 230–231 replaced by PT,
thereby reconstituting the chagasin consensus
motif NPTTG; PbICP-CMut2: residues 273–297 re-
placed by GGG; PbICP-CMut3,4: residues 256–295
deleted and replaced by GGG, respectively;
PbICP-CMut5: residues 256–272 deleted). Results
are shown in percent residual protease activity
estimated from a control sample without protease
inhibitor. Continuous black lines indicate residues
identical to the wild-type; deletions (dashed lines)
and replaced residues are shown in gray. All
experiments were done in triplicate with standard
deviations indicated by error bars.
Structure
Structure of PbICP-C in Complex with FP-2and L2 to supply a stable interaction surface. Adjacent to
Arg336i, residue Pro337i is located in a hydrophobic pocket
formed by Ala157p and Phe158p and has structural functions
in shaping L6 to enable optimal binding to the protease. Finally,
the highly conserved L6 residue Phe338i is packed against
a cluster of aromatic FP-2 residues (Phe156p, Tyr159p,
Phe164p, Trp206p, and Trp210p) that maintains the proper
orientation of the catalytic-triad residue Asn204p (Ljunggren
et al., 2007).
Unlike L2, L4, and L6, which all bind into the active site groove
of FP-2, the tip of L0 contacts FP-2 at a distance of approxi-
mately 10 A˚ from the substrate-binding cleft (Figure 2). L0 resi-
dues 201GNISNQT207 are located close to the surface of the
protease, but only Asn205i is involved in direct interactions
with FP-2. A hydrogen bond to the side-chain hydroxyl of
Ser108p (2.8 A˚) and weaker interactions with the main-chain
carbonyl and amide of Asn38p (3.3 and 3.8 A˚) are formed (Fig-
ure 2, inset L0). The position and orientation of L0 induce a signif-
icant movement of the side chain of Asn38p. In the complex with
PbICP-C, Asn38p is deeply buried by L0, L2, and L4, whereas it
is exposed to bulk solvent in free FP-2. L0 seems to push the side
chain of Asn38p toward L2, thereby bringing it in position for an
amide-p interaction with Tyr234i that might further contribute to
the overall binding affinity of PbICP-C.
In addition to loops L0, L2, L4, and L6, residues of L3 are
involved in less-pronounced van der Waals contacts with FP-2.
As discussed above, loop L3 harbors a sequence insertion (resi-
dues 250–264) that distinguishes PbICP-C from other chagasin-
like inhibitors. In PbICP-C the extended L3 is able to cover the
length of the front sheet and forms a ridge (residues 254–258)
in proximity to FP-2 (Figure S1B). Residues Lys256i and
Leu257i of this ridge bury the side chain of Phe158p, and thereby
possibly increase the affinity of PbICP-C to its target. In agree-
ment with this the removal of residues 256–295 or replacement
by triple-glycine (GGG) negatively affects the inhibition of several
CPs. Corresponding variants show a reduced inhibitory effect on
FP-2 (residual protease activity in the presence of: PbICP-C,Structure 19,18%; PbICP-CMut3, 56%; PbICP-CMut4, 33%), on papain
(PbICP-C, 5%; PbICP-CMut3, 64%; PbICP-CMut4, 53%), and on
EhCPs (PbICP-C, 13%; PbICP-CMut3, 67%; PbICP-CMut4,
68%) (Figure 3). An additional variant, PbICP-CMut5 (D256–
272) that carries a shorter deletion restricted to the L3 region,
shows similar results (residual protease activity of: FP-2, 53%;
papain, 28%; and EhCPs, 68%) (Figure 3), indicating that the
observed effect is mainly due to the loss of interactions with L3
and not L4.
In 2006, Pandey et al. (2006) reported that falstatin efficiently
inhibits a wide range of CPs, including FP-2, papain, and
cathepsin L. We show here that in both, PbICP and PfICP, this
activity is localized to the C-terminal domain, whereas the
N-terminal domains of PbICP and PfICP do not have any effect
on proteolysis of peptide substrates (Figure 4). In contrast to
chagasin (Ljunggren et al., 2007; Redzynia et al., 2008), neither
PbICP-C nor PfICP-C is able to inhibit cathepsin B (Figure 4). A
characteristic feature of the cathepsin B structure is the pres-
ence of a loop region that ‘‘occludes’’ substrates from binding
to the primed subsites of the active site cleft (Musil et al.,
1991). Steric repulsion between the PbICP-C insertions in L3
or L4 and the occluding loop of cathepsin B would represent
an attractive explanation for the observed specificity. Therefore,
we tested if our ‘‘chagasin-like’’ PbICP-C variants lacking inser-
tions within L3 and L4 can rescue the inhibition of cathepsin B.
Like wild-type PbICP-C, none of these variants shows any effect
on proteolytic degradation by cathepsin B (Figure 3), indicating
that the amino acid insertions in PbICP are not responsible for
the lack of inhibition of cathepsin B. Also, Pandey et al. (2006) re-
ported that in addition to papain-like enzymes, PfICP is able to
inhibit to some extent more distantly related CPs. In contrast
to these findings, in our hands neither full-length PfICP nor
PbICP, nor the C-terminal or N-terminal domains alone, dis-
played any activity against calpain-1, caspase-3, or caspase-8
(Figure 4). As we tried to replicate the assay conditions reported
by Pandey et al. (2006) as closely as possible, we cannot explain
the contrasting results.919–929, July 13, 2011 ª2011 Elsevier Ltd All rights reserved 923
Figure 4. Inhibition of CPs by Plasmodium ICPs
Substrate hydrolysis by FP-2, papain, cathepsin L (cat L), cathepsin B (cat B),
calpain-1 (cal-1), caspase-8 (cas-8), and caspase-3 (cas-3) was determined in
the presence of purified full-length ICP, ICP-C, or ICP-N from P. berghei (A) or
P. falciparum (B). Results are shown in percent residual protease activity
estimated from a control sample without protease inhibitor. All experiments
were done in triplicate with standard deviations indicated by error bars.
Structure
Structure of PbICP-C in Complex with FP-2Comparative Analysis of FP-2 Inhibitor Complexes
In addition to our binary complex with PbICP-C, structures of
FP-2 with cystatin (Wang et al., 2006), chagasin (Wang et al.,
2007), and the cysteine-protease inhibitor E64 (Kerr et al.,
2009) have been reported. Unlike cystatin, a macromolecular
cysteine-protease inhibitor unrelated to ICPs, E64 is a potent,
epoxide-based irreversible small molecule inhibitor (Figure S1C).
The available structural data allow a detailed comparison of how
structurally diverse inhibitors achieve the deactivation of FP-2.
In all four complexes the shape of the substrate-binding cleft
of FP-2 is essentially conserved, and none of the inhibitors
induces major conformational changes in FP-2 upon binding
(rmsd <0.63 A˚ for Ca atoms). The angle of approach, t, of
PbICP-C relative to FP-2 (3.3) is very similar to that of chagasin
(5.4) (definition of t as in Redzynia et al., 2009; for details see
Supplemental Experimental Procedures). Superimpositions of
the complexes show that loops L2, L4, and L6 of chagasin and
PbICP-C are well aligned and interact with identical regions of
the FP-2 substrate-binding cleft (Figure S2). Interestingly, the
same interaction sites are also occupied by two loops of cystatin
that harbor residues 54i–56i (accessing L2 interaction sites), resi-
dues 103i–104i (accessing L6 interaction sites), and the
N-terminal residues 7i–8i (accessing L4 interaction sites) (Fig-
ure S2). All macromolecular complexes exhibit large buried
surface areas (FP-2:PbICP-C, 2650 A˚2; FP-2:chagasin,
1950 A˚2; FP-2:cystatin, 1750 A˚2). In contrast the buried
surface area in the FP-2:E64 complex is much smaller
(700 A˚2), and E64 interacts with nonprimed subsites of FP-2
(Figure S2) only, which in case of PbICP-C and chagasin are
occupied by L4.924 Structure 19, 919–929, July 13, 2011 ª2011 Elsevier Ltd All rightIn chagasin and LmICP, L2 is critical for the interaction with
target proteases (dos Reis et al., 2008; Smith et al., 2006).
However, in PbICP the L2 motif NPTTG(Y/F), which is usually
highly conserved in I42 family members, is replaced by
229NAGTGY234. Lacking the Pro and harboring an additional
Gly, the main chain of L2 in PbICP-C has greater conformational
freedom compared to chagasin. A structural superimposition
confirmed that the two amino acid exchanges in PbICP-C cause
a major rearrangement of the main chain of residues 228i–231i
(3.4 A˚ difference in the position of Ca atoms of chagasin
Pro30i and the corresponding PbICP-C Ala230i), whereas
the conserved residues 232i–234i align almost perfectly. This
suggests that depending on the amino acid composition, L2
can adopt two alternative conformations that both enable effi-
cient inhibition of various target proteases. Accordingly, we
show that a replacement of NAGTG by NPTTG in PbICP-C
does not significantly alter inhibition of FP-2, papain, and EhCPs
(Figure 3). Furthermore, the replacement of the Pro by Ala in an
inhibitory peptide harboring the L2 motif NPTTG did abolish inhi-
bition of papain and EhCPs (Riekenberg et al., 2005). Thus, for
the majority of ICPs, either a Pro at position 2 (e.g., in chagasin)
or a Gly at position 3 of the L2 motif (in Plasmodium ICPs) seems
to be required to allow for interaction with target CPs.
The nonprimed subsites of FP-2 accommodate the L4 loop of
PbICP-C and chagasin (Wang et al., 2007). Main-chain torsion
angles of L4 and spatial restrictions that prohibit large side
chains dictate the presence of a Gly at position 5 of the L4 motif
(L/M)(L/V)GXGG (307MQLLGG312 in PbICP). Hence, this Gly is
strictly conserved in all ICPs described thus far (except in toxos-
tatin-1 and -2 from Toxoplasma gondii, both of which completely
lack the L4 sequence motif; Huang et al. [2009]). A main-chain
hydrogen-bonding interaction to Asn173p seems to be impor-
tant for tight binding of macromolecular inhibitors because it is
conserved in all complexes except in that with E64 (residue in:
PbICP, Gly311i; chagasin, Gly66i; cystatin, Gly6i). FP-2 has
a strong preference for Leu at the S2 subsite, and accordingly,
in all four inhibitor complexes a Leu is found to occupy this
pocket (Kerr et al., 2009; Wang et al., 2006, 2007). In addition
to favorable van der Waals contacts, the S2 interaction is stabi-
lized by two hydrogen bonds between the main-chain amide as
well as the carbonyl of Gly83p and the backbone of the inhibitor
molecules (Leu310i in PbICP). The predominantly hydrophobic
S3 pocket accommodates a second Leu in PbICP (Leu309i),
chagasin (Leu64i), and cystatin (Leu7i), or the hydrophobic
region of the (4-guanidino)butane moiety in E64 (Figure S1C).
In contrast to L2 and L4, residues in the L6 motif RPW/F are
highly conserved in ICPs. The most prominent interaction
between L6 and FP-2 in the PbICP-C complex is a strong salt
bridge between Arg336i and Asp35p, which is also present in
the complex with chagasin (residue Arg91i) (Wang et al., 2007).
Our structure suggests that Thr232i of L2 helps to maintain
the optimal binding geometry of Arg336i. Indeed, in chagasin
a corresponding hydrogen bond (between Arg91i and Thr32i) is
present in all structures of the inhibitor in its free form (Figueiredo
da Silva et al., 2007; Ljunggren et al., 2007; Salmon et al., 2006)
as well as in all protease complexes (Ljunggren et al., 2007; Red-
zynia et al., 2008, 2009;Wang et al., 2007). To further stabilize the
side-chain conformation, the Arg is sandwiched between the
Phe or Trp at position 3 of the motif and an aromatic residue ofs reserved
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Structure of PbICP-C in Complex with FP-2L2 (PbICP-C, Tyr234i; chagasin, Phe34i). In line with this inter-
pretation, replacement of the Trp by Ala led to a 100-fold reduc-
tion of cathepsin L inhibition by chagasin (dos Reis et al., 2008).
In LmICP the L6motif most likely plays a similar role but seems to
be less important for tight binding because the simultaneous
replacement of the L6 residues Arg and Phe by Ala resulted
in a modest 3-fold increase of Ki against CPB, a CP from
Leishmania mexicana.
In summary all three macromolecular inhibitors, PbICP-C,
chagasin, and cystatin, bind to identical regions within the
substrate-binding cleft of FP-2. Most interactions responsible
for the formation of a stable inhibitor:protease complex are
well conserved even between the structurally unrelated ICP
and cystatin inhibitor families. E64 binds to the active site cleft
at a position occupied by L4 of ICPs and by residues 7i–8i of
cystatin. Although a covalent complex between the active site
cysteine of FP-2 and E64 is formed, additional interactions of
the small molecule inhibitor are similar to those observed in the
noncovalent ICP and cystatin complexes. In contrast the interac-
tion between L0 of PbICP-C and FP-2 is unique and has not been
observed in any other complex.
PbICP-C Does Not Target Cathepsin B and SERA5
It is interesting to note that PbICP-C is a potent inhibitor of
various papain-like proteases including cathepsin L (Rennen-
berg et al., 2010), but not of the related cathepsin B. To explain
this discrepancy at a structural level, we superimposed the
PbICP-C:FP-2 complex onto available structures of chagasin
complexes with cathepsin L (Ljunggren et al., 2007) and
cathepsin B (Redzynia et al., 2008) (Figure 5A). In line with our
results on PbICP-CMut2–5 variants, the superimposition shows
that the insertions within L3 and L4 can be easily accommodated
by cathepsin B, do not lead to unfavorable contacts, and, thus,
cannot explain the observed specificity of PbICP-C (Figure 5A).
In contrast, L0 and L6 of PbICP-C sterically clash with the
occluding loop, which is limiting the access to the primed
subsites in cathepsin B and the related cathepsin X (Musil
et al., 1991; Sivaraman et al., 2000). Unfavorable contacts
include L0 residues 202i–204i and L6 residues 341i–343i with
residues 119p–121p and 108p–109p of the occluding loop,
respectively (Figure 5B).
Plasmodium species infecting mammals encode at least five
members of the SERA family that have been implicated to play
a role during egress from erythrocytes (Blackman, 2008). The
best-studied member of the family, SERA5, is highly expressed
in parallel with ICP in the late blood stage just before erythro-
cyte rupture (Miller et al., 2002), and in P. berghei-infected
hepatocytes processed forms of ICP and SERA homologs
are found in the host-cell cytoplasm (Putrianti et al., 2010;
Rennenberg et al., 2010). To evaluate if SERA5 is a possible
target for Plasmodium ICP, we superimposed the structure of
P. falciparum SERA5 (Hodder et al., 2009) onto FP-2 in the
complex with PbICP-C (rmsd 1.6 A˚ for 181 Ca atoms) and
analyzed the interface of PbICP-C and SERA5 (Figure 5A). In
contrast to cathepsin B, SERA5 does not contain an occluding
loop element, and no obvious steric hindrance prevents the
interaction with PbICP-C in this region (Figure 5A). Furthermore,
all favorable contacts of loops L0, L2, and L6 that stabilize the
complex with FP-2 would also be possible in a complex withStructure 19,SERA5. In contrast the nonprimed subsites of SERA5 cannot
accommodate L4 of PbICP-C (Figure 5A, inset): (1) Ser640p
(corresponding to Gly83p in FP-2) is not in position to form
hydrogen bonds to Leu310i; (2) the S1 and S2 subsites are
severely restricted by Asp594p and Tyr735p, respectively;
and (3) the S3 subsite is more open and strongly negatively
charged, therefore, not well suited to accommodate the hydro-
phobic side chain of Leu309i. In consequence our structural
data analysis shows that SERA5 most likely cannot bind
Plasmodium ICPs, suggesting independent functions for both
proteins upon release into the cytoplasm of the host cell.
Function of ICP in Plasmodium
We and others have previously shown that PbICP and PfICP
are critical for the invasion of host cells, both erythrocytes and
hepatocytes (Pandey et al., 2006; Rennenberg et al., 2010).
ICPs are expressed in sporozoites (shown for P. gallinaceum
and P. berghei), liver-stage schizonts (shown for P. berghei),
blood-stage merozoites, early rings, and late schizonts (shown
for P. falciparum). Dependent on the parasite stage, ICPs get
into contact with the parasite cytoplasm, the parasitophorous
vacuole, the host-cell cytoplasm, or the extracellular space
(LaCrue et al., 2006; Pandey et al., 2006; Rennenberg et al.,
2010). Because CPs are abundant in the parasite, in the host
cell, and even in extracellular compartments, the assignment
of a specific function for Plasmodium ICPs is difficult.
A first clue on possible target proteases came from experi-
ments with antibodies directed against PbICP or PfICP that
blocked host-cell invasion and parasite development (Pandey
et al., 2006; Rennenberg et al., 2010). This can be explained by
PfICP preventing deleterious proteolytic activity of FP-2 during
the invasion process of erythrocytes. FP-2 is found in large
quantities inside the digestive food vacuole where hemoglobin
degradation takes place, and at later stages, it is likely released
into the medium after schizont rupture. Therefore, it is possible
that uncontrolled activity of extracellular FP-2 interferes with
the coordinated serine protease-mediated proteolysis neces-
sary for host-cell invasion (Baum et al., 2008). Potentially
destructive FP-2 activity might be prevented by ICP, which is
highly expressed before schizont rupture (Pandey et al., 2006).
A second possible function of Plasmodium ICPs is closely
connected to the observation that infection with P. berghei
prevents host cells from undergoing programmed cell death
(van de Sand et al., 2005). Because PbICP-C translocates into
the host-cell cytoplasm, it has been postulated that the inhibitor
is involved in regulating the activity of proapoptotic host-cell CPs
such as caspases. Although we could not confirm calpain-1,
caspase-3, or caspase-8 as targets, it is possible that ICPs
prevent premature host-cell death by inhibition of cathepsin-
like host-cell CPs, which are frequently involved in the execution
of cell death. In this context it is important to note that heterolo-
gous expression of PbICP-C in hepatoma cells protects them
from cell death induced by peroxide or camptothecin treatment
(Rennenberg et al., 2010). However, at the final stages of intra-
cellular development of Plasmodium, the parasite needs to
activate host-cell death to facilitate parasite transport into blood
vessels (Sturm et al., 2006). Host-cell death is induced by, so far,
unknown CPs, but because PbICP is found in large quantities in
the host cell at the time cell death occurs, it is safe to assume that919–929, July 13, 2011 ª2011 Elsevier Ltd All rights reserved 925
Figure 5. Models for Interaction of PbICP-C with Cathepsin L, Cathepsin B, and SERA5
(A) Models of complexes of PbICP-C (ribbon representation) with host proteases (surface representation) based on superposition of FP-2 and cathepsin B (PDB
code: 3CBJ), cathepsin L (PDB code: 2NQD), or SERA5 (PDB code: 2WBF). Close-up of inhibitor:protease interaction sites shown as insets highlighting steric
clashes in complexes with cathepsin B and SERA5. Colors are as in Figure 1.
(B) Structure-based sequence alignment of FP-2, SERA5, cathepsin L, and cathepsin Bwith FP-2 residue numbering indicated. Boxes show residues responsible
for steric clashes in cathepsin B (occluding loop) and SERA5 (nonprimed subsites S1–S3).
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Structure
Structure of PbICP-C in Complex with FP-2the CPs at play are not inhibited by PbICP. Thus, Plasmodium
ICPs might suppress apoptosis before the parasite is ready to
leave the host cell and later guarantee a slow and ordered
host-cell death possibly executed by, so far, unknown cathepsin
B-like CPs.
In conclusion our results provide structural details on a new
class of protease inhibitors from Plasmodium and its interaction
with target parasite CPs, exemplified by FP-2. The structure of
PbICP-C reveals unique structural elements that explain the effi-
cient and specific inhibition of a subset of CPs. Our conclusions
are supported by functional data based on PbICP-C variants de-
signed on the basis of the three-dimensional structure. Structural
information on the binding motifs of ICPs might offer valuable
starting points for the rational design of protease inhibitors
and, thus, is of high relevance for the development of new, effec-
tive drugs. It has already been shown that a peptide harboring
the L2 motif of ICP from E. histolytica acts as an efficient
cystein-protease inhibitor (Riekenberg et al., 2005). Because
FP-2 is currently one of the main targets for the development
of new antimalarial drugs, the structure of its complex with
ICP-C will further our understanding of how efficient inhibition
of this enzyme by small molecule inhibitors can be achieved.
EXPERIMENTAL PROCEDURES
Recombinant Protein Production, Crystallization,
and X-ray Data Collection
Production, purification of PbICP-C, and preparation of the complex with
FP-2 Cys42Ala (a mature, inactive variant of the FP-2 precursor, previously
designated FPc285aM [Hogg et al., 2006]), as well as crystallization and
subsequent X-ray data collection, will be published elsewhere in detail. Briefly,
PbICP-C was produced in E. coli BL21 (DE3) cells and purified by nickel-
affinity chromatography. After buffer exchange to 500 mM NaCl, 20 mM Tris
(pH 7.5), PbICP-C was concentrated to 6 mg/ml.
FP-2 Cys42Ala was recombinantly produced as previously described (Hogg
et al., 2006), with slight modifications. PbICP-C (5 mg) and FP-2 Cys42Ala
(5 mg) were mixed (final concentration 1 mg/ml each) and incubated overnight
at 4C. The complex was isolated by size-exclusion chromatography, concen-
trated to 2 mg/ml in 500 mM NaCl, 20 mM Tris (pH 7.5), and crystallized using
the sitting-drop vapor-diffusion technique by mixing equal volumes of protein
solution and reservoir. The best crystals were obtained when using 200 mM
sodium acetate, 27.5 mM CdCl2, and 100 mMMES (pH 5.0) as reservoir solu-
tion. X-ray diffraction data to a resolution of 2.6 A˚ were collected at 100 K from
a single crystal using synchrotron radiation (wavelength = 0.9184 A˚) at BESSY
(Berlin), beamline BL14.1. Crystals belonged to space group P43, with unit cell
parameters a = 71.15 A˚ and c = 120.13 A˚. Diffraction data were processed,
reduced, and scaled with MOSFLM (Leslie, 1992) and SCALA (Evans, 2006).
Data collection statistics are summarized in Table 1.
Structure Determination
The structure of PbICP-C:FP-2 was determined by molecular replacement
with Phaser (Storoni et al., 2004) using the coordinates of FP-2 (PDB code:
2GHU, monomer A) (Hogg et al., 2006) as search model. The main chain of
a PbICP-C molecule adjacent to the FP-2 molecule was manually traced by
iterative cycles of model building using Coot (Emsley and Cowtan, 2004)
and refinement with REFMAC (Murshudov et al., 1997) and Phenix (Afonine
et al., 2005). Refinement statistics are shown in Table 1. The final model
comprises 239 residues of FP-2 (A2–A241) and 118 residues of PbICP-C
(B195–B275; B307–B354), 3 glycerol molecules, 2 Cd2+ ions, and 54 water
molecules. Figures were made with PyMOL (DeLano, 2002).
Inhibition Studies
For inhibition studies the following proteins were produced in E. coli BL21
cells, and purified by amylose-affinity chromatography: PbICP, PbICP-C,Structure 19,PbICP-N, PfICP, PfICP-C, PfICP-N, the variants PbICP-CMut1–5, and chagasin.
Ki values were determined using standard protocols. Because the N-terminal
maltose-binding protein (MBP) tag used for purification did not affect the inhib-
itory activity of PbICP-C or PfICP-C, it was not cleaved off prior to protease
assays described below.
PbICP-C or PbICP-CMut1–5 and various proteases were incubated with
suitable chromogenic substrates. Product formation after 10 min incubation
in the presence of 1 mM PbICP-C or PbICP-CMut1–5 was used to determine
the residual protease activity relative to a control sample without protease
inhibitor.
The effect of ICP, ICP-C, or ICP-N from P. berghei or P. falciparum on the
activity of FP-2, papain, cathepsin L (V. Turk, Jozef Stefan Institute, Ljubljana),
cathepsin B (Sigma), calpain-1 (Calbiochem), caspase-8 (Calbiochem), and
caspase-3 (Calbiochem) was determined using suitable peptide substrates in
a fluorimetric protease assay. All measurements were performed in triplicate.
For details on inhibition assays, see Supplemental Experimental Procedures.ACCESSION NUMBERS
Coordinates and structure factors have been deposited into the Protein Data
Bank with accession code 3PNR.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and two figures and can be found with this article online at doi:10.1016/j.str.
2011.03.025.
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